SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Idea: AMPK Agonist Therapy for Neurodegeneration

idea 710 words KG: AMPK 2026-03-23

kind:idea kind:therapy-idea section:ideas state:published

Contents

AMPK Agonist Therapy for Neurodegeneration

Knowledge Graph

Related Hypotheses (30)

SASP-Mediated Complement Cascade Amplification
Score: 0.70 Transcriptional Autophagy-Lysosome Coupling
Score: 0.66 Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65 CYP46A1 Overexpression Gene Therapy
Score: 0.63 Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.62

Digital Twin-Guided Metabolic Reprogramming
Score: 0.61 Senescence-Activated NAD+ Depletion Rescue
Score: 0.60 Multi-Modal Stress Response Harmonization
Score: 0.60 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59 Circadian-Synchronized Proteostasis Enhancement
Score: 0.58 Microbial Inflammasome Priming Prevention
Score: 0.58 PARP1 Inhibition Therapy
Score: 0.58 AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.57 Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57 Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57 SASP-Mediated Cholinergic Synapse Disruption
Score: 0.56 Smartphone-Detected Motor Variability Correction
Score: 0.56 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 Purinergic Signaling Polarization Control
Score: 0.55 Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55 Blood-Brain Barrier SPM Shuttle System
Score: 0.55 Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55 Senescent Cell Mitochondrial DNA Release
Score: 0.54 Retinal Vascular Microcirculation Rescue
Score: 0.54 APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54 Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54 Senescence-Induced Lipid Peroxidation Spreading
Score: 0.53 Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53

Related Analyses (30)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived

Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Extracellular vesicle biomarkers for early AD detection
neurodegeneration · completed Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic reprogramming in aging neurons
neurodegeneration · archived Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived Microglial subtypes in neurodegeneration — friend vs foe
neuroscience · failed Epigenetic reprogramming in aging neurons
neurodegeneration · completed GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed

Related Experiments (30)

iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · proposed · Score: 0.90 AMPK knockdown validation experiment
exploratory · proposed · Score: 0.88 iPSC-NPC transplantation in ICH animal model
validation · proposed · Score: 0.85 Germfree mouse colonocyte energy metabolism analysis
validation · proposed · Score: 0.90 Proposed experiment from debate on Astrocytes adopt A1 (neur
falsification · proposed · Score: 0.40

Metabolic Pathway-Targeted Therapy in ALS
clinical · proposed · Score: 0.40 Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40 Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson'
clinical · proposed · Score: 0.40 Mechanism: Selective Vulnerability of Dopaminergic Neurons i
validation · proposed · Score: 0.40 Selective Vulnerability of Dopaminergic Neurons — Mechanism
validation · proposed · Score: 0.40 ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 GLP-1 Agonist Neuroprotection Mechanism in PD
clinical · proposed · Score: 0.40 GLP-1 Agonist Responder Prediction Study — Precision Medicin
clinical · proposed · Score: 0.40 Cytochrome Therapeutics
clinical · proposed · Score: 0.40 Metabolic Syndrome-Parkinson's Disease Axis Clinical Trial
clinical · proposed · Score: 0.40 Peroxisome Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 Selective Neuronal Vulnerability to Aging — Mapping Why Spec
validation · proposed · Score: 0.40 Sirtuin Pathway Dysfunction Validation in Parkinson's Diseas
clinical · proposed · Score: 0.40 Proposed experiment from debate on Astrocytes adopt A1 (neur
falsification · proposed · Score: 0.40 s:** - Biochemical binding assays measuring PROTAC selectivi
falsification · proposed · Score: 0.40 Proposed experiment from debate on Epigenetic clocks and bio
falsification · proposed · Score: 0.40 Proposed experiment from debate on Microglia activate astroc
falsification · proposed · Score: 0.40 Proposed experiment from debate on Epigenetic clocks and bio
falsification · proposed · Score: 0.40 s:** - Temporal analysis showing mitochondrial defects prece
falsification · proposed · Score: 0.40 s:** - Test MCU overexpression specifically in layer II neur
falsification · proposed · Score: 0.40 Proposed experiment from debate on TDP-43 undergoes liquid-l
falsification · proposed · Score: 0.40 Proposed experiment from debate on TDP-43 undergoes liquid-l
falsification · proposed · Score: 0.40 s:** - Compare uptake with/without magnetic particles using
falsification · proposed · Score: 0.40 Proposed experiment from debate on Perivascular spaces and g
falsification · proposed · Score: 0.40 s:** - Test tau spreading in AQP4 knockout vs wild-type mice
falsification · proposed · Score: 0.40

See Also (15)

Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 123 hypotheses WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 123 hypotheses vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 123 hypotheses VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 123 hypotheses Vagus Nerve Pathway in Neurodegeneration
mechanism · Pages share 123 hypotheses

Ubiquitin-Proteasome System Dysfunction in Neurodegener
mechanism · Pages share 123 hypotheses ubiquitin-proteasome-dysfunction-neurodegeneration
mechanism · Pages share 123 hypotheses Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 123 hypotheses Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 123 hypotheses Therapeutic Targets in Neurodegeneration
mechanism · Pages share 123 hypotheses Tertiary Lymphoid Organs in Neurodegeneration
mechanism · Pages share 123 hypotheses Tau Kinase Signaling Cascade in Alzheimer's Disease
mechanism · Pages share 34 hypotheses T-Cell Dysfunction in Neurodegeneration
mechanism · Pages share 123 hypotheses Synthetic Lethality and PARP Inhibition in Neurodegener
mechanism · Pages share 123 hypotheses synaptic-vesicle-cycling-neurodegeneration
mechanism · Pages share 123 hypotheses

Knowledge Graph (12 edges)

AMPK associated_with APOE

AMPK associated_with PINK1

AMPK associated_with Dementia

AMPK associated_with STAT3

AMPK associated_with Mapk

AMPK associated_with Fibrosis

AMPK associated_with Neuroinflammation

AMPK associated_with JUN

AMPK associated_with TNF

AMPK associated_with NRF2

SciDEX — scidex.ai — Dashboard | Atlas